Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Ceftazidime × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Specimen Handling 5 Dexamethasone 5 Rituximab 4 Prednisone 4 Cisplatin 4 Carboplatin 4 darolutamide 3 Vincristine 3 Tobacco Use Cessation Devices 3 Magnetic Resonance Spectroscopy 3 Letrozole 3 Injections 3 Hydromorphone 3 Bevacizumab 3 trametinib 2 ribociclib 2 pirtobrutinib 2 pembrolizumab 2 obinutuzumab 2 gadolinium ethoxybenzyl DTPA 2 enzalutamide 2 enfortumab vedotin 2 dabrafenib 2 Watchful Waiting 2 Thalidomide 2 Standard of Care 2 Propofol 2 Paclitaxel 2 Oxaliplatin 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04948463 2025-12-24

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡